Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury

BACKGROUND & AIMS: The occurrence of drug‐induced liver injury (DILI) is a major issue in all phases of drug development. To identify novel biomarker candidates associated with DILI, we utilised an affinity proteomics strategy, where antibody suspension bead arrays were applied to profile plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikus, Maria, Drobin, Kimi, Gry, Marcus, Bachmann, Julie, Lindberg, Johan, Yimer, Getnet, Aklillu, Eleni, Makonnen, Eyasu, Aderaye, Getachew, Roach, James, Fier, Ian, Kampf, Caroline, Göpfert, Jens, Perazzo, Hugo, Poynard, Thierry, Stephens, Camilla, Andrade, Raúl J., Lucena, M Isabel, Arber, Nadir, Uhlén, Mathias, Watkins, Paul B., Schwenk, Jochen M., Nilsson, Peter, Schuppe‐Koistinen, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215406/
https://www.ncbi.nlm.nih.gov/pubmed/27224670
http://dx.doi.org/10.1111/liv.13174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215406/
https://www.ncbi.nlm.nih.gov/pubmed/27224670
http://dx.doi.org/10.1111/liv.13174

Ejemplares similares